Ivermectin Patent Expiration

Ivermectin is Used for treating inflammatory lesions of rosacea. It was first introduced by Merck Sharp And Dohme Corp in its drug Stromectol on Nov 22, 1996. Other drugs containing Ivermectin are Soolantra, Sklice. 8 different companies have introduced drugs containing Ivermectin.


Ivermectin Patents

Given below is the list of patents protecting Ivermectin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Soolantra US10206939 Treatment of papulopustular rosacea with ivermectin Mar 13, 2034 Galderma Labs Lp
Soolantra US9089587 Treatment of papulopustular rosacea with ivermectin Mar 13, 2034 Galderma Labs Lp
Soolantra US9233117 Treatment of inflammatory lesions of rosacea with ivermectin Mar 13, 2034 Galderma Labs Lp
Soolantra US9233118 Treatment of papulopustular rosacea with ivermectin Mar 13, 2034 Galderma Labs Lp
Soolantra US9782425 Treatment of papulopustular rosacea with ivermectin Mar 13, 2034 Galderma Labs Lp
Sklice US8791153 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice Oct 12, 2027 Arbor Pharms Llc
Sklice US8927595 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice Oct 12, 2027 Arbor Pharms Llc
Soolantra US11033565 Topical application of ivermectin for the treatment of dermatological conditions/afflictions Apr 22, 2024

(Expired)

Galderma Labs Lp
Soolantra US7550440 Topical application of ivermectin for the treatment of dermatological conditions/afflictions Apr 22, 2024

(Expired)

Galderma Labs Lp
Soolantra US8080530 Topical application of ivermectin for the treatment of dermatological conditions/afflictions Apr 22, 2024

(Expired)

Galderma Labs Lp
Soolantra US8093219 Topical application of ivermectin for the treatment of dermatological conditions/afflictions Apr 22, 2024

(Expired)

Galderma Labs Lp
Soolantra US8415311 Topical application of ivermectin for the treatment of dermatological conditions/afflictions Apr 22, 2024

(Expired)

Galderma Labs Lp
Soolantra US8470788 Topical application of ivermectin for the treatment of dermatological conditions/afflictions Apr 22, 2024

(Expired)

Galderma Labs Lp
Soolantra US8815816 Topical application of ivermectin for the treatment of dermatological conditions/afflictions Apr 22, 2024

(Expired)

Galderma Labs Lp
Soolantra US6133310 Method of treatment of rosacea Apr 26, 2019

(Expired)

Galderma Labs Lp
Soolantra US5952372 Method for treating rosacea using oral or topical ivermectin Sep 18, 2018

(Expired)

Galderma Labs Lp
Sklice US6103248 Topical preparation and therapy for head lice May 22, 2018

(Expired)

Arbor Pharms Llc



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ivermectin's patents.

Given below is the list recent legal activities going on the following patents of Ivermectin.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 05 Jul, 2023 US9233118
Payment of Maintenance Fee, 8th Year, Large Entity 05 Jul, 2023 US9233117
Payment of Maintenance Fee, 12th Year, Large Entity 03 Jul, 2023 US8093219
Payment of Maintenance Fee, 12th Year, Large Entity 13 Jun, 2023 US8080530
Payment of Maintenance Fee, 8th Year, Large Entity 19 Jan, 2023 US9089587
Payment of Maintenance Fee, 4th Year, Large Entity 10 Aug, 2022 US10206939
Payment of Maintenance Fee, 8th Year, Large Entity 17 Feb, 2022 US8815816
Payment of Maintenance Fee, 8th Year, Large Entity 31 Jan, 2022 US8791153
Recordation of Patent Grant Mailed 15 Jun, 2021 US11033565
Patent Issue Date Used in PTA Calculation 15 Jun, 2021 US11033565


Ivermectin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Ivermectin Generics

Several generic applications have been filed for Ivermectin. The first generic version for Ivermectin was by Edenbridge Pharmaceuticals Llc and was approved on Oct 24, 2014. And the latest generic version is by Zydus Lifesciences Global Fze and was approved on Aug 2, 2022.

Given below is the list of companies who have filed for Ivermectin generic.


1. EDENBRIDGE PHARMS

Edenbridge Pharmaceuticals Llc has filed for 1 generic for Ivermectin. Given below are the details of the strengths of this generic introduced by Edenbridge Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3MG tablet Prescription ORAL AB Oct 24, 2014


2. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Ivermectin. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1% cream Prescription TOPICAL AB Apr 13, 2020


3. TARO

Taro Pharmaceutical Industries Ltd has filed for 1 generic for Ivermectin. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5% lotion Over the counter TOPICAL N/A May 6, 2020


4. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Ivermectin. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1% cream Prescription TOPICAL AB Sep 13, 2019
0.5% lotion Discontinued TOPICAL N/A Mar 21, 2022


5. ZYDUS LIFESCIENCES

Zydus Lifesciences Global Fze has filed for 1 generic for Ivermectin. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1% cream Prescription TOPICAL AB Aug 2, 2022